Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatment. [electronic resource]
- Acta haematologica 2007
- 236-7 p. digital
Publication Type: Case Reports; Comment; Letter
1421-9662
10.1159/000099548 doi
Antineoplastic Agents--therapeutic use Benzamides Blast Crisis Genes, abl Humans Imatinib Mesylate Immunophenotyping In Situ Hybridization, Fluorescence Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy Male Middle Aged Piperazines--therapeutic use Pyrimidines--therapeutic use Reverse Transcriptase Polymerase Chain Reaction